May 2013 Issue

Commentary

Hemoglobin Levels Fall, Transfusions On the Rise

Expert Q&A

New Prostate Center to Focus on Improving Everything from Diagnosis to Treatment: An Interview with Ashutosh K. Tewari, MB, BS

Subscribe
Archive

Subscribe

Editorial Board	Login \| Register

Get the App

Download our free app for iOS or Android

July 27, 2010

Long-Term Study of Multi-target Therapy as Continuous Induction and Maintenance Treatment for Lupus Nephritis

Long-Term Study of Multi-target Therapy as Continuous Induction and Maintenance Treatment for Lupus Nephritis

Sponsor and Collaborators
Nanjing University School of Medicine

Contact
Contact: Haitao Zhang, Master
0086-25-80860218
haitaozh@yahoo.com.cn

Principal Investigator
Zhihong Liu, Master Research Institute of Nephrology, Jinling Hospital

ClinicalTrials.gov Identifier
NCT01056237

Next Article in Lupus Nephritis Clinical Trials

Rituximab in Progressive IgA Nephropathy

RUN Articles

MEmbranous Nephropathy Trial Of Rituximab (MENTOR)

A look at the following clinical trial: MEmbranous Nephropathy Trial Of Rituximab (MENTOR).

Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With ...

A look at the following clinical trial: Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy (RITULUP).

Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis ...

A look at the following clinical trial: Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis (RITUXILUP).